Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Medigene AG
MDG1Current price
1.54 EUR
-0.16 EUR (-9.29%)
Last closed
1.63 EUR
Company
www.medigene.com
ISIN
DE000A1X3W00
Sector
Healthcare
Industry
Biotechnology
Exchange
XETRA Stock Exchange
Capitalization
24 077 186 EUR
Yield for 12 month
-57.52 %
1Y
3Y
5Y
10Y
15Y
MDG1
Medigene AG, a biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer. The company's end-to-end platform enables the development of T cell receptor engineered T cell (TCR-T) therapies for multiple tumor indications. Its pipeline includes MDG1015, a TCR-T therapy product to treat multiple solid tumor indications; MDG10xx to treat multiple solid tumor; and MDG1011, a TCR-T immunotherapy candidate, which is in clinical development to treat blood cancer. It also focuses on dendritic cell vaccines. Medigene AG has a strategic partnership with BioNTech to develop TCRbased immunotherapies against cancer; and 2seventy bio, Inc. for the development of TCR immunotherapies, as well as a collaboration agreement with National Cancer Institute to evaluate the potential of T cell receptors to be used in new cell constructs for the treatment of solid tumors. It has operations in Germany, the United States, and Asia. The company has research collaboration with WuXi Biologics to design and co-research TCR-guided T Cell engagers (TCR-TCEs) for the treatment of difficult-to-treat tumors. Medigene AG was founded in 1994 and is headquartered in Munich, Germany. Address: Lochhamer Strasse 11, Munich, Germany, 82152
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.57 EURP/E ratio
–Dividend Yield
–Current Year
+6 092 643 EUR
Last Year
+31 550 682 EUR
Current Quarter
+1 471 160 EUR
Last Quarter
+2 259 750 EUR
Current Year
+3 009 972 EUR
Last Year
+29 548 411 EUR
Current Quarter
+1 134 924 EUR
Last Quarter
+1 869 495 EUR
Key Figures MDG1
1 year
3 years
5 years
10 years
EBITDA
-14 924 654 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.15 %
PEG Ratio
–
Return On Equity TTM
-63.93 %
Wall Street Target Price
5.57 EUR
Revenue TTM
7 518 366 EUR
Book Value
1.35 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-6 %
Dividend Yield
–
Gross Profit TTM
29 548 410 EUR
Earnings per share
-1.22 EUR
Diluted Eps TTM
-1.22 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-213.98 %
Dividend Analytics MDG1
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MDG1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:2
Payout Ratio
–
Last Split Date
29.08.2024
Dividend Date
–
Stock Valuation MDG1
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.6608
Price Sales TTM
3.1272
Enterprise Value EBITDA
1.8128
Price Book MRQ
1.2129
Financials MDG1
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MDG1
For 52 weeks
1.57 EUR
5.56 EUR
50 Day MA
1.99 EUR
Shares Short Prior Month
–
200 Day MA
2.65 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart